We are live on ! Find out more
ELAN icon

Elanco Animal Health

370 hedge funds and large institutions have $12.6B invested in Elanco Animal Health in 2019 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 153 increasing their positions, 107 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 85 | Existing positions closed: 55

43% more repeat investments, than reductions

Existing positions increased: 153 | Existing positions reduced: 107

8% more funds holding

Funds holding: 344370 (+26)

6% more capital invested

Capital invested by funds: $12B → $12.6B (+$670M)

0.31% more ownership

Funds ownership: 102.23%102.54% (+0.31%)

18% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $24.9M

22% less funds holding in top 10

Funds holding in top 10: 97 (-2)

Holders
370
Holders Change
+26
Holders Change %
+7.56%
% of All Funds
8.04%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.15%
New
85
Increased
153
Reduced
107
Closed
55
Calls
$20.4M
Puts
$24.9M
Net Calls
-$4.56M
Net Calls Change
+$39.3M
Name Holding Trade Value Shares
Change
Change in
Stake
MSL
226
Mackay Shields LLC
New York
$649K +$372K +11,455 +148%
SAM
227
Shell Asset Management
Netherlands
$628K +$260K +8,020 +76%
CL
228
CSS LLC
Illinois
$616K -$300K -9,235 -34%
II
229
IFM Investors
Australia
$593K +$570K +17,551 New
JC
230
Jacobs & Co
California
$589K -$33.4K -1,028 -6%
Skandinaviska Enskilda Banken (SEB)
231
Skandinaviska Enskilda Banken (SEB)
Sweden
$575K +$552K +17,000 New
BTS
232
BB&T Securities
Virginia
$565K +$36.1K +1,111 +7%
NIT
233
NumerixS Investment Technologies
British Columbia, Canada
$551K -$2.73M -84,194 -84%
GCA
234
Greenwood Capital Associates
South Carolina
$549K +$232K +7,155 +79%
SC
235
Saturna Capital
Washington
$545K +$107K +3,300 +26%
MLICM
236
Metropolitan Life Insurance Company (MetLife)
New York
$534K -$8.64K -266 -2%
Mariner
237
Mariner
Kansas
$532K +$511K +15,739 New
PG
238
Pendal Group
Australia
$519K -$27.8K -856 -5%
Comerica Bank
239
Comerica Bank
Texas
$509K +$115K +3,541 +30%
SG Americas Securities
240
SG Americas Securities
New York
$508K -$733K -22,591 -60%
SACTSONJ
241
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$507K +$487K +15,000 New
PCM
242
Parsons Capital Management
Rhode Island
$504K +$46.6K +1,434 +11%
AIM
243
Achmea Investment Management
Netherlands
$481K +$462K +14,237 New
RCA
244
Rowland Carmichael Advisors
Arizona
$467K -$6.92K -213 -2%
BRWA
245
B. Riley Wealth Advisors
Florida
$466K +$129K +3,965 +40%
GC
246
Guggenheim Capital
Illinois
$453K +$435K +13,397 New
Los Angeles Capital Management
247
Los Angeles Capital Management
California
$445K +$428K +13,170 New
AAP
248
Ardsley Advisory Partners
Connecticut
$442K
SMDAM
249
Sumitomo Mitsui DS Asset Management
Japan
$437K -$132K -4,079 -24%
M&T Bank
250
M&T Bank
New York
$433K +$416K +12,825 New

ELAN Hedge Fund Activity: Q2 2019 in Review

370 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q2 2019, worth a combined $12.6B — up 5.6% from $12B a quarter earlier.

Buyers outnumbered sellers: 85 funds opened new ELAN positions and 55 closed out — a net gain of 30 holders — while 153 added to existing stakes and 107 trimmed.

The largest buyer was Invesco, adding an estimated $315M. The largest seller was Citadel Advisors, cutting an estimated $183M.

  • 370 institutional investors held Elanco Animal Health (ELAN) as of Q2 2019, up from 344 in Q1 2019.
  • Funds reported $12.6B of Elanco Animal Health stock for Q2 2019, up 5.6% quarter-over-quarter.
  • 85 funds opened new Elanco Animal Health positions in Q2 2019 and 55 closed out, a net change of +30 holders.
  • The largest Elanco Animal Health buyer in Q2 2019 was Invesco, an estimated $315M added.
  • The largest Elanco Animal Health seller in Q2 2019 was Citadel Advisors, an estimated $183M sold.

Based on aggregated 13F filings for Q2 2019.